The precise incidence and prevalence of idiopathic normal-pressure hydrocephalus (INPH) is not known, and evidence-based clinical diagnostic criteria have not been developed previously. This report contains evidence-based guidelines for clinical diagnosis of INPH that are intended to facilitate future epidemiological studies of INPH, promote earlier and more accurate diagnosis, and ultimately improve treatment outcome.
gait assessment, functional brain imaging, and other procedures. These test are not required routinely but may increase confidence in the diagnosis in selected cases.
A cerebrospinal fluid (CSF) opening pressure (CSF-OP) measured by lumbar puncture in the lateral recumbent position is useful in confirming that pressure is within the range expected for INPH (60-240 mm H 2 O).
The diagnosis of INPH is complicated by the variability that exists in its clinical presentation and course. INPH can resemble, or occur in combination with, various disorders that are prevalent in the elderly, such as cerebrovascular disease, neurodegenerative disorders (e.g., Alzheimer's, Parkinson's, Lewy body disease), primary urological disorders, spinal stenosis, and other conditions. Accordingly, it may be useful to classify INPH into "probable," "possible," and "unlikely" categories, operationally defined by the extent to which the expected elements of INPH are present and diagnostic confounders can be excluded. "Shunt responsiveness" is considered separately as a measure of treatment outcome and does not enter into this diagnostic classification (see Part III).
OVERVIEW
Three and a half decades after Hakim and Adams (22) described the entity of "symptomatic occult hydrocephalus with 'normal' CSF pressure," the validity of the concept of INPH has been challenged (14, 18 ). The precise incidence and prevalence of INPH are not known, formal diagnostic criteria have not been developed, spinal fluid pressure is not truly normal, and the natural history of untreated INPH has not been studied systematically. Nevertheless, it would do a great disservice to many patients not to acknowledge the existence of the INPH syndrome when its potentially incapacitating symptoms can be improved or even cured by shunt placement. The ataxia, dementia, and incontinence associated with more advance stages of INPH tend to be less responsive to treatment than milder symptoms of less than 2 years' duration (36) . Thus, early and accurate diagnosis of INPH can be instrumental in achieving an optimal treatment outcome and avoiding potentially severe and irreversible impairments.
Advances in INPH research and clinical practice have been hampered by the lack of widely accepted, standardized criteria for its diagnosis. Various authors have described systematic means of selecting INPH cases for inclusion in studies (3, 9, 45, 46) . Although these criteria have merit, they are neither evidence-based nor supported by a broad consensus. As a consequence, they have not been widely adopted in practice by clinicians or investigators. Compounding this problem, there are no generally accepted neuropathological criteria for postmortem confirmation of a diagnosis of INPH. Discrete abnormalities, such as arachnoid fibrosis, have been reported on brain autopsies of selected patients with INPH but occur too infrequently to be useful in validating clinical diagnosis (2) .
Diagnostic sensitivity for INPH is reduced by the variability that exists in its clinical presentation and course. Diagnostic specificity is reduced owing to the common occurrence of other conditions in the elderly, such as cerebrovascular disease and certain neurodegenerative disorders, with symptoms closely resembling those of INPH. In addition, although INPH can readily be distinguished from several other conditions that involve ventricular enlargement, these distinctions are not made consistently in actual practice. For example, adult age of onset can be used to distinguish INPH from childhood-onset forms of hydrocephalus. Secondary hydrocephalus can be differentiated from INPH by virtue of its identifiable precipitants. Cerebral atrophy cannot predominate in INPH as it does in so-called "hydrocephalus ex vacuo." Reduced flow through the aqueduct of Sylvius is a distinguishing feature of aqueductal stenosis, whereas macroscopic blockage of the ventricular system is characteristic of noncommunicating hydrocephalus. In the recently described syndrome of long-standing overt ventriculomegaly in adults, enlargement of head circumference and/or destruction of the sella turcica are obligate features required for diagnosis (34) . Although all of these disorders have some features in common with INPH, they can follow a very different course or require different management strategies. The clinical features and prognosis in INPH are sufficiently unique for it to be considered a discrete clinical syndrome warranting its own diagnostic and management guidelines.
Certain authors (35) have suggested that the only reliable means of validating a diagnosis of INPH is to document a positive response to shunt placement. However, this approach would yield an unacceptable rate of incorrect diagnostic classifications. False-negatives would occur when patients with true INPH have an absent or diminished response to shunt placement owing to coexisting conditions (e.g., Alzheimer's, Parkinson's, cerebrovascular disease, etc.), postoperative complications (e.g., subdural hematomas, infections), inadequate treatment (e.g., overdrainage or underdrainage), or mechanical failures (e.g., shunt malfunction). False-positive diagnoses result because patients with similar conditions, such as aqueductal stenosis, secondary NPH, and noncommunicating hydrocephalus, often respond favorably to shunt placement and because placebo responses sometimes occur (23) . Studies have reported that prolonged positive response occurred in as few as 29% of INPH cases, suggesting that there may be a poor correlation between shunt responsiveness and the selection criteria now used in INPH studies. For these and other reasons, shunt responsiveness should not be used as the basis for diagnosis of INPH.
A large number of test procedures, invasive and noninvasive, have been developed to assist in the diagnosis of and prognostication about INPH. Nevertheless, INPH is routinely diagnosed on the basis of convergent evidence from clinical history, examination, and brain imaging. Additional tests may improve diagnostic confidence, promote differential diagnosis, or assist in prognosticating about response to shunt placement. However, no single test in isolation has been found to supplant the combination of clinical assessment and neuroimaging as the basis for diagnosis of INPH. The association To acknowledge that different degrees of diagnostic certainty follow routine assessments in different cases, a classification system of "probable," "possible," and "improbable" INPH has been proposed (45) . The present consensus criteria distinguish between basic findings required for the diagnosis of INPH and adjunctive measures that may support a diag- 
95 A multicenter study of NPH in which patients were followed up for 1 year. Scales were developed for scoring gait disturbance and dementia. CT scan with an Evans' index Ͼ0.3 and a ventricular index Ͼ0.8 coupled with the sum of the four largest sulci at the convexity, measured at the two upper CT slices, being Ͻ25 millimeter was classified typical of NPH. The resistance to outflow of CSF Ͼ18 mm Hg/ml/min was designated as a positive test outcome.
II
The accurate predictive value of the combination of the clinical and CT findings was 0.65. The positive results of outflow resistance, clinical, and CT findings was 0.74. Typical clinical symptoms and CT evidence of NPH is important in predicting shunt outcome. The measurement of CSF outflow resistance increases the number of shunt responders.
Jonas and Brown, 1975 (24) 4 Five patients of whom four had INPH were evaluated by urological procedures. The bladder difficulties observed were urinary frequency and urgency incontinence. Cystometry was believed to be the key study. Findings were those of the socalled "uninhibited neurogenic bladder," in which there is loss of inhibitory impulses from descending tracts. With loss of inhibitory impulses, the bladder contracts, resulting in frequent voidings.
III Bladder dysfunction related to dementia or gait difficulty was eliminated in this study. The study supported the possibility that bladder dysfunction in INPH is neurogenic. Identification of the sites within the nervous system where the dysfunction arose could not be made. All other patients had at least gait disorder; 30 patients had CT scans that showed large ventricles and minimal cortical atrophy without evidence of obstruction to CSF flow. There were no other pathological changes. Fifteen patients did not have CT scans before surgery because they were shunted before the introduction of CT scans. Instead, they underwent radioisotope CSF cisternography. Follow-up period after the surgery ranged from 10 to 157 mo.
III Patients who had initial gait disturbance of Ͻ2 yr were most likely to improve (74%). This is followed by improvement in incontinence (65%) and dementia (57%). CT scan played an important role in the diagnosis and follow-up. Twenty five of the 30 patients (83%) who had preoperative CT scans improved after the surgery. Conversely, 9 of the 15 patients (60%) who did not have preoperative CT scans improved. The improvement (83 versus 60%) was achieved with the help of CT scans, the experience of the clinician, and the positive ancillary tests. Complication rate was 30%.
Vanneste et al., 1993 (45) 89 A retrospective study of combined clinical and CT data was used to create an ordinal global scale to predict the clinical outcome of 112 shunted patients for presumed NPH, of which 89 were INPH. The clinical and CT findings were used to define the categories of probable, possible, and improbable SR-NPH patients.
III Probable SR-NPH group had an overall improvement of 58% (95% CI, 37-77%). Shunting patients of improbable SR-NPH would have led to improvement in 13% (95% CI, 4 -27%). The best strategy was to shunt probable SR-NPH, which would have led to predictive accuracy of 75% (95% CI, 66 -84%). The study illustrated the need to assess the pretest probability of NPH based on clinical and CT findings before establishing the clinical usefulness of ancillary tests.
nosis of INPH. A description of the probable, possible, and unlikely INPH entities is presented in Table 2 .1, and these categories have been modified on the basis of contributions from the work of other investigators. Prospective validation of these criteria will require studies of interrater reliability, construct validity, sensitivity, and specificity, as well as correlation with shunt responsiveness. It is our hope that the formulation of consensus criteria will promote improved clinical recognition of INPH and stimulate additional research about this syndrome.
PROCESS
The criteria for the diagnosis of INPH described here are based on evidence from the medical literature, supplemented as necessary by expert opinion. From 1966 to 2003, 653 publications on "normal-pressure hydrocephalus" were cited in MEDLINE, including 29 articles that met the more stringent criteria of including "idiopathic normal-pressure hydrocephalus" in their title (see Evidentiary Data, Table 2 .2). Additional studies were considered that explicitly identified cases of INPH and/or specified the criteria for a diagnosis of INPH. Studies were graded according to the class of evidence and results summarized in evidentiary tables. For issues of clinical relevance that lacked substantive evidence from the medical literature, the opinions of consulting experts (see Part I) were considered and contributed to "options."
SCIENTIFIC FOUNDATION Features of INPH Derived from Clinical History
Evaluations of suspected INPH are typically performed by neurosurgeons, neurologists, psychiatrists, geriatricians, and/or internists (3). INPH may be suspected as a result of incidental findings of ventriculomegaly on a brain imaging study performed for other purposes. In other cases, clinical complaints trigger suspicion of INPH. INPH should be considered in the differential diagnosis of any unexplained disturbance of gait, continence, and cognition that begins insidiously in an adult. This is most commonly a gait disturbance, followed in frequency by cognitive impairments and least often, urinary incontinence (9, 10) .
Patients with INPH may have impairments of insight and/or memory that impede their ability to provide an accurate personal history. In cases of suspected INPH involving cognitive impairment, it is therefore important to obtain the clinical history from both the patient and a knowledgeable informant who is familiar with the patient's premorbid and current levels of function. When eliciting the history, particular attention should be paid to the mode of onset of symptoms 
Family and personal histories of psychiatric disturbances should therefore be reviewed, and inquiries should also be made about neurovegetative signs (disturbances of sleep, appetite, libido, motivation).
Documentation of symptoms involving control of urination is important, because in-office assessment of urinary function is usually limited unless a urological referral is made. Patients should be encouraged to document their urinary symptoms for a period of at least 1 week, noting frequency of urination, episodes of urinary urgency, nocturia, and frank incontinence (24) .
The differential diagnosis of INPH ( Table 2. 3) includes a large number of conditions that are relatively commonplace in the elderly. A review of past medical and surgical history is therefore an important part of the evaluation. Cerebrovascular disease and its risk factors are among the most important of these conditions (10) . Hypertension has been reported, in some cases, to develop in parallel with symptomatic INPH. Common disorders that affect gait in the elderly and may complicate the diagnosis of INPH include spinal stenosis, peripheral neuropathy, and vestibular problems. Prostatism in men and chronic urinary tract infections in women can cause symptoms similar to those of INPH and should be excluded as the cause of urinary symptoms.
Features of INPH Derived from Brain Imaging
As part of the routine evaluation of suspected INPH, a brain imaging study (typically magnetic resonance imaging [MRI] or computed tomography [CT]) must be performed to assess ventricular size and to rule out ventricular obstruction. Ventricular enlargement is documented by an Evan's index of 0.3 or greater or an equivalent measure reflecting an increased ratio of ventricular size to cranial diameter (16) .
MRI is more expensive than CT and cannot be administered to patients with certain pacemakers, ferromagnetic metallic implants, or severe claustrophobia. Yet, MRI offers several advan- Several other brain imaging techniques have been studied as potential adjuncts to the diagnosis of INPH, but at present, none have been proven to increase diagnostic accuracy beyond routine structural brain imaging. Functional imaging techniques, including perfusion imaging with single-photon emission computed tomography (SPECT) and SPECT/acetazolamide challenge, resting metabolic imaging with positron emission tomography, and nuclear cisternography are not recommended as part of the routine evaluation of suspected INPH. Positron emission tomography and SPECT may be abnormal in INPH, but the diagnostic value of these techniques has not been established.
Clinical Symptoms of INPH
There is considerable variation in the nature, severity, and course of progression of the symptoms of INPH. The natural history of untreated INPH has not been well characterized, and it is not clear whether all cases ultimately progress, nor is the tempo of progression established for the majority of cases. Progression of symptoms is generally expected but may not be uniform over the course of the disease. Symptoms of INPH in the early stage and late stages of the disease may differ dramatically, as may symptoms in previously treated versus untreated patients.
All three components of the so-called classic triad of INPH need not be present for the diagnosis of INPH to be made. Gait disturbance tends to be the most readily recognized feature of INPH. Cognitive disturbances do not occur in all patients, and the severity of cognitive and motor symptoms does not necessarily correlate at baseline or progress in parallel. Incontinence in INPH is difficult to distinguish from urinary symptoms associated with other common disorders. The signs and symptoms of INPH are typically bilateral but may appear lateralized when superimposed on coexisting conditions, such as stroke, radiculopathy, and peripheral neuropathy.
Movement Disorders

Gait
Early descriptions emphasized cognitive symptoms as the primary clinical manifestation of NPH. Ojemann et al. (35) were among the first to report that gait disturbance could be an initial manifestation of NPH. Fisher (17) later documented that among 16 patients with successfully shunted NPH, gait disturbance preceded dementia in 12 and was affected concomitantly in 3. Only 1 patient in that series had dementia as the initial manifestation. However, because cognitive symptoms of INPH can be subtle and may go undetected unless tested formally, it remains to be seen whether gait disturbance is an earlier symptom or more prevalent than dementia in a majority of cases.
The origin of the gait disturbance in INPH is not entirely understood. An early hypothesis suggested that enlargement of the ventricles in INPH led to compression and/or deformation of the upper motor neuron fibers passing through the medial portion of the corona radiata. Although pyramidal tract involvement is not supported by a recent study using motor evoked responses (3), involvement of premotor pathways has not been ruled out. Electromyographic evidence reveals contraction of antagonistic muscle groups and abnormally increased activity in the antigravity muscles acting on hip and knee joints (2, 9) . This suggests that the gait disorder of INPH is a disturbance in the phased activation of muscle groups, as would be seen in a disorder of subcortical motor control rather than a primary pyramidal tract disturbance. With progression of INPH and/or the evolution of extensive subcortical white matter changes, pyramidal tract involvement may become more likely. Although flexor plantars are typically observed early in the course of INPH, reflex changes, including extensor plantar responses, may be expected at later stages. A possible contribution of subcortical dopaminergic pathways to the gait and movement disturbances is discussed below in the section on other movement disorders associated with INPH.
Detailed studies of the gait of patients with clinically diagnosed and radiologically confirmed INPH reveal several characteristics that may be useful in the clinical differential diagnosis of INPH. The pattern of gait seen in INPH patients has been variably described as "apractic," "bradykinetic," "glue-footed," "magnetic," "parkinsonian," "short-stepped," and "shuffling." Gait problems may emerge as difficulty in ascending or descending stairs and curbs and in walking at the expected pace. Patients may complain of difficulty rising from a chair, "give-way" weakness of the lower extremities, and fatigue brought on by walking. As the disease progresses, turning in place becomes tenuous and typically requires multiple steps (en bloc). Weakness of the legs is not usually evident on neurological examination in such patients, and pyramidal dysfunction is therefore not considered a common symptom of INPH.
Computerized analysis of the gait of INPH patients has shown 1) reduced cadence, 2) decreased step height, and 3) reduced counterrotation of the shoulders relative to the pelvis during walking. The upward angular movement of the foot during stepping is inadequate in INPH, and stride length is diminished. The step width and foot rotation angles are reportedly increased, and there is less step-to-step variability in these parameters than in normal controls (35) .
The gait findings in INPH may coexist with other conditions but should not be entirely attributable to structural lesions of the brain or spine (such as tumors, strokes, vascular malformation, stenosis, etc.), systemic medical conditions (such as infections, metabolic abnormalities, inflammatory disorders, cancer), or neurodegenerative conditions (idiopathic Parkinson's disease, amyotrophic lateral sclerosis, etc.) ( Table 2. 3).
Posture
Disturbance of both gait and stance were recognized early in the history of NPH research, giving rise to the term "hydrocephalic astasia-abasia" (17) . The stance in INPH may be more forward leaning than in healthy normal individuals, and INPH patients tend to show a wider sway and imbalance that may be accentuated by eye closure (6, 48) .
Other Movement Disorders, Including Parkinsonism
Other movement disorders may be as common as the widely recognized gait disturbance of INPH. Apraxias of limb and trunk movements, particularly in the vertical direction, are commonly observed. INPH patients sometimes show a dramatic inability to ascend onto the examining table or climb into their own bed at home. Once recumbent, they may have great difficulty turning or shifting their position without assistance or simulating walking movements while recumbent.
Akinetic, tremulous, hypertonic, or hyperkinetic movement disorders have been described in NPH patients and may be seen more frequently in patients with idiopathic forms of the disorder (26) . Bradykinesia affects the upper extremities in the form of slow movement in as many as half of NPH patients, whereas frank parkinsonism has been reported as a symptom of NPH in as many as 11% of patients (25) .
The plausibility of an association between NPH and Parkinson's disease in humans is supported by the creation of reversible parkinsonian symptoms in animal models of hydrocephalus (43) . Symptoms consistent with parkinsonism that have been reported to occur in NPH include bradykinesia, tremor, rigidity with or without cogwheeling, decreased arm swing, shuffling gait, festination, retropulsion, masked facies, hypophonia, decreased eye blink rate, difficulty initiating movements, postural instability, dyssynergia, and drooling. Cognitive symptoms resembling the dementia seen in some patients with idiopathic Parkinson's disease have also been described in association with INPH, as have frontal release signs such as snout and grasp responses. Parkinson's disease-like symptoms in INPH patients may be l-dopa-responsive or -unresponsive and may or may not respond dramatically to shunt placement. One mechanism that has been postulated for parkinsonian symptoms in INPH is compromise of nigrostriatal dopaminergic pathways brought about by abnormal pulsatile CSF flow affecting the substantia nigra and/or striatum, causing a disturbance in motor planning (42) .
Although incontinence is one of the originally described features of INPH, it is the least well characterized. Increased frequency and urgency without actual urinary incontinence may be seen in early stages of the disorder, with progression to frank urinary incontinence with disease progression. Incontinence is not an invariable component of the disorder and may occur rarely or just intermittently in some cases. Fecal incontinence is not a usual presenting symptom of INPH, although it may well develop later in the course of the disorder, particularly if it is left untreated.
Patients in more advanced stages of INPH may show indifference to the episodes of incontinence, suggesting that the incontinence is associated with frontal executive dysfunction. In other patients, gait disturbance, apraxia, and bradykinesia may act to physically restrain the individual from performing successful toileting. This results in functional incontinence despite retained insight, normal sensation of bladder fullness, or otherwise normal bladder function.
The term "neurogenic bladder syndrome" has been used in association with NPH (43) . Hyperactivity of the urinary bladder can be detected by urodynamic studies in some cases (19, 41) , with strong contractions elicited by infusions of small volumes of fluid into the bladder. Urodynamic studies may be helpful in distinguishing INPH-related frequency, urgency, and incontinence from common comorbid conditions in the age groups most prone to develop INPH, such as prostatism in men, recurrent urinary tract infections in women, and bladder dystonia/dysautonomia in either sex.
Cognitive and Behavioral Manifestations
Dementia
The principal cognitive symptoms seen in INPH are suggestive of a subcortical dementing process, including slowing of thought, inattentiveness, and apathy, as well as encoding and recall problems (30) . True aphasia is unusual in INPH, although speech output may be disturbed secondary to dysexecutive or motivational problems. The locus of dysfunction responsible for dementia in INPH remains unclear, although the frontostriatal system has been implicated by some investigators. Others emphasize the importance of other subcortical structures, including projection fibers passing in proximity to the lateral ventricles. The severity of cognitive impairments seen in INPH encompasses a full spectrum from minimally detectable to profoundly severe. In mild stages, differential diagnosis may be particularly difficult owing to overlap of INPH-related cognitive impairment with that seen in more prevalent disorders, such as Alzheimer's disease. This overlap occurs because patients with Alzheimer's disease have presenting problems in multiple cognitive domains. The essential criteria for clinical diagnosis of Alzheimer's disease is included in Table 2 .4, and a comparison of cognitive deficits with Alzheimer's disease and INPH is presented in Table 2 .5. As INPH progresses, cognitive impairments may become more generalized and more refractory to treatment. Nevertheless, even patients with fairly advanced dementia may still respond positively to shunt placement (4).
When possible, quantifiable measures of cognitive performance (neuropsychological tests) should be used. The impairments detected should not be attributable to other conditions such as neurodegenerative disorders, stroke, head trauma, psychoactive medications, or other identifiable factors.
Psychiatric Manifestations
Although cognitive changes such as memory impairment, attentional disturbances, and bradyphrenia are usually cited as the main features of the dementia associated with INPH, behavioral disturbances have also been reported. Case reports of a variety of psychiatric disorders in association with INPH have appeared, including depression (38, 39) , mania (bipolar disorder) (4, 40) , aggressivity (15, 28) , obsessive compulsive disorder (1), psychosis including paranoia and hallucinations (7, 27, 37) , and disturbance of impulse control (21) .
The appearance of symptoms of depression in patients with INPH could be a neurochemical consequence of the underlying brain disorder. However, it could also arise in response to the physical and mental disabilities associated with INPH. An additional possibility is that what seems to be depression is actually a look-alike syndrome brought about by the psychomotor retardation and cognitive changes commonly seen in INPH. Whatever the pathogenesis, psychiatric presentations in INPH are important to recognize, both because they may complicate clinical diagnosis and because they may be refractory to conventional pharmacological interventions and respond more favorably to shunt treatment in some cases.
Other Symptoms of NPH and Symptoms Not Expected
Case reports and case series have reported a variety of symptoms that represent infrequently seen but reproducibly 
Measurement of CSF-OP
The concept that a "normal" CSF pressure is a defining feature of INPH has been criticized (12, 14) . In normal volunteers, the CSF-OP averages 122 Ϯ 34 mm H 2 O (8.8 Ϯ 0.9 mm Hg) when measured by lumbar puncture in the left lateral recumbent position (8) . In patients with INPH, the CSF-OP measured by lumbar puncture in the lateral recumbent position averages 11 Ϯ 3.3 mm Hg (150 Ϯ 45 mm H 2 O) but may fall between 4.4 and 17.6 mm Hg (60-240 mm H 2 O). The lumbar CSF-OP of INPH therefore averages slightly higher than normal but overlaps the range of pressures observed in normal subjects. This is in contrast to the acute and secondary forms of hydrocephalus, which may be associated with pressures well in excess of normal and outside the physiological range. Transient high pressures ("B waves") are detectable during prolonged intraventricular monitoring in adults with symptomatic INPH (20) . CSF-OP is a poor measure of the complex temporal profile of intraventricular pressure variations that occur in hydrocephalus patients. However, the normal or modestly elevated average pressures typically observed in INPH stand in contrast to the sustained, elevated pressures commonly recorded in acute and noncommunicating forms of hydrocephalus. CSF-OP measurement may be most useful in identifying hydrocephalic conditions other than INPH, particularly when the OP is elevated above 18 mm Hg (245 mm H 2 O). Expert opinion reflects that pressure elevations above this level more likely indicate secondary or noncommunicating hydrocephalus than INPH. Determination of the CSF-OP is therefore recommended when lumbar puncture or other drainage procedures are performed (which is typically performed in an effort to prognosticate about shunt responsiveness), because the CSF-OP can provide information relevant to a diagnosis of INPH.
CSF-OP in the range of 105 to 190 mm H 2 O is consistent with a diagnosis of probable INPH, assuming that all other diagnostic criteria have been met. In the absence of an OP measurement or with results at the extremes of the expected range (60-104 or 191-240 mm H 2 O), INPH would be considered "possible." CSF-OP outside this range makes a diagnosis of INPH unlikely. Manometric measurement of OP on lumbar puncture is the most common method for determining CSF pressure as part of the evaluation of hydrocephalus. When lumbar puncture is performed in the left lateral decubitus position, the zero point of the manometer is being positioned at the approximate height of the atrium of the heart. Before a pressure reading is made, the patient should be fully relaxed, preferably with the legs extended, for a period of 5 minutes after the spinal needle is introduced. Pulsation of the CSF column should be visible in synchrony with the heartbeat to ensure that the end of the needle is in good continuity with the subarachnoid space at the time of measurement.
Shunt-responsive and Shunt-nonresponsive INPH
Some INPH patients may be refractory to treatment and will not respond to shunting despite a diagnosis of "probable" INPH. The term shunt-nonresponsive (see Part III) will refer to those patients independent of diagnostic category (probable, possible, unlikely). Similarly, although it may be expected that a higher proportion of "probable" INPH patients will respond to shunting, we have applied the term "shunt-responsive" to any diagnostic category, probable, possible, or unlikely, that responds favorably to surgical intervention.
On the basis of clinical presentation alone, evidence shows that favorable response to shunting will vary from 46 to 63% (see Part III). Black (5) reported that the best indicator for shunt responsiveness was patients with the complete triad and achieved a 61.2% rate of improvement and a 35.4% complication rate. Because these data would include patients in the "probable" category, one can appreciate the value of adjunctive testing to predict shunt responsiveness. A subsequent report deals with the value of other tests beyond that of clinical presentation described here and estimates the degree of certainty of achieving a positive response to shunting. These tests include CSF lumbar tap, external lumbar drainage, or CSF resistance studies (11) . We would expect that patients with "probable" INPH would have proportionally more positive adjunctive tests, if implemented, than categories of "possible and unlikely." We also posit that patients with "probable" INPH and a positive adjunctive test will have the highest percentage of favorable responses to shunting compared with the other categories.
SUMMARY AND RECOMMENDATIONS
INPH is best classified into probable, possible, and unlikely categories. It is our hope that these criteria will be widely applied in clinical practice and promote greater consistency in
